drug safety

What should be done about Health Canada?

Submitted by Carlyn Zwarenstein on September 29, 2014 - 11:38

This weekend the Toronto Star published a thought-provoking op-ed arguing that in the light of Health Canada's incompetence or outright neglect (summed up pretty well in an editorial published today in the same paper) in failing to demand that Apotex pull tainted or poor quality drugs off their shelves--along with other failures to p

Drug safety in the news

Submitted by Carlyn Zwarenstein on September 11, 2014 - 22:34

We've looked at the issue of drug safety from different angles through various Open Medicine papers. Never this one though. In today's Toronto Star. 

Drug safety in the news

Submitted by Carlyn Zwarenstein on April 13, 2014 - 15:34
Topics: 

Open Medicine contributors Joel Lexchin and David Juurlink are both featured in Saturday's Toronto Star article on secrecy around Health Canada drug safety reviews. In fact, Dr.

OM in the Globe & Mail: caution needed on newly-approved drugs

Submitted by Carlyn Zwarenstein on January 29, 2014 - 14:10

Our latest study is garnering some attention, including in this article in the Globe & Mail. And on the Twittersphere! Join us at https://twitter.com/OpenMedicine or follow @OpenMedicine.

Media release: How Safe Are New Drugs? Market Withdrawal of Drugs Approved in Canada between 1990 and 2009

Submitted by Carlyn Zwarenstein on January 28, 2014 - 06:55

Open Medicine

A peer-reviewed, independent, open-access journal.

FOR IMMEDIATE RELEASE

A York University study of drug safety published today in Open Medicine shows that new drugs are often on the market in Canada for more than three years before they are withdrawn as unsafe, raising concerns about turning to the newest drugs available.

Access to vital information: drug safety edition

Submitted by Carlyn Zwarenstein on January 26, 2014 - 17:27

With the recent news that the main Health Canada research library in Ottawa has closed, with inter-library loans (i.e.